Aurobindo Pharma Announces Business Transfer Agreements With Apitoria Pharma For API Business Sales

Aurobindo Pharma Announces Business Transfer Agreements With Apitoria Pharma For API Business Sales

The shares of Aurobindo Pharma Limited on Friday at 3:30 pm IST closed at Rs 917, up by 4.97 percent.

FPJ Web DeskUpdated: Sunday, October 01, 2023, 12:50 PM IST
article-image
Aurobindo Pharma Announces Business Transfer Agreements With Apitoria Pharma For API Business Sales | Aurobindo

Aurobindo Pharma Limited on Sunday announced that the Company had entered into Business Transfer Agreements (BTA) with Apitoria Pharma Private Limited (formerly known as Auro Pharma India Private Limited) (hereinafter referred to as Apitoria), a wholly-owned subsidiary of the Company for sale/transfer of the API Non-Antibiotic Business operated through its operating manufacturing plants, (Unit I, Unit VIII, Unit IX, Unit XI, Unit XIV (integrated unit) and R&D Unit 02) and API Antibiotic Business of the Company operated through its operating manufacturing plants, (Unit V & Unit XVII), respectively, (both excluding the land and buildings pertaining to the said divisions), as a going concern on slump sale basis, the company announced through an exchange filing.

Through the regulatory filings, the company said that in terms of the respective BTAs, the sale/transfer of the Company’s API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete on September 30, 2023 and consequently the API Non-Antibiotic Business and API Antibiotic Business shall be undertaken from Apitoria with effect from October 1, 2023.

The key regulatory approvals in respect of the above business transfers were received on September 30, 2023, and the consequent restrictions to account the business transfer with effect from April 1, 2023, it is proposed to make the aforesaid business transfers effective from October 1, 2023.

Aurobindo Pharma Limited shares

The shares of Aurobindo Pharma Limited on Friday at 3:30 pm IST closed at Rs 917, up by 4.97 percent.

RECENT STORIES

Finance Minister Nirmala Sitharaman Announces Collateral-Free Loans Of Up To ₹100 Crore For MSMEs

Finance Minister Nirmala Sitharaman Announces Collateral-Free Loans Of Up To ₹100 Crore For MSMEs

'Putting India On India’s Map': Comedian Kunal Kamra Takes A Dig At Ola Electric; Here's How...

'Putting India On India’s Map': Comedian Kunal Kamra Takes A Dig At Ola Electric; Here's How...

Singapore Police, Banks Work Together To Prevent 1,338 Scams And Avert SGD 53 Million Losses During...

Singapore Police, Banks Work Together To Prevent 1,338 Scams And Avert SGD 53 Million Losses During...

Divi's Laboratories Q2FY25 Consolidated Profit Surges By 51.5% YoY; Income Jumps 35% To ₹2,637.9...

Divi's Laboratories Q2FY25 Consolidated Profit Surges By 51.5% YoY; Income Jumps 35% To ₹2,637.9...

Medtech Leaders Welcome Govt's Move To Launch ₹500 Crore Scheme For Medical Devices

Medtech Leaders Welcome Govt's Move To Launch ₹500 Crore Scheme For Medical Devices